Mar 14, 2011
Attend this webinar to understand the differences and benefits of verification and validation. Learn about the risks and complications involved with the application of sound verification and validation principles.
Mar 14, 2011
This cGMP webinar for medical device companies will focus on recent manufacturing lapses that have resulted in major recalls, multi-million dollar fines and some criminal charges. It will analyze why they happened and show how to prevent it.
Mar 14, 2011
Understanding of latest FDA guidance requirements and expectations related to medical device tracking and what are the new changes.
Mar 14, 2011
This webinar will discuss in detail the FDA regulations and the regulatory process with respect to medical device complaint handling and reporting.
Mar 10, 2011
This cGMP training will help you in understanding systematic plan of evaluating cGMP applicable to the IND product cycle, the regulatory mandates risk-management strategy and potential consequences for failures in inadequate assessment.
Mar 10, 2011
This webinar will review FDA's regulatory oversight of stem cell-based products when used in humans and analyze its potential impact on the industry in the future. Learn FDA's criteria for marketing and promotion of stem cell-based products.
Mar 10, 2011
This webinar will discuss multiple Quality Control Tools used in manufacture of pharmaceutical and biotech products, their purpose, advantages and disadvantages. You will learn how to implement cGMP compliance related to Quality Systems Operations.
Mar 10, 2011
This training will help you understand FDA expectations for reduced testing of Pharmaceutical & Medical Device components and will develop your confidence in maintaining control of supplier quality.
Mar 10, 2011
This webinar will focus on the key attributes of an effective cGMP investigation, the role of management, employing quality control tools, CAPA effectiveness checks and Warning Letters associated with cGMP compliance.
Mar 10, 2011
This USP 1226 webinar training will discuss the requirements of USP 1226, what are FDA expectations related to method verification.